Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy ; volume:9 ; number:11 ; year:2017 ; pages:1558-1573 ; extent:16
EMBO molecular medicine / European Molecular Biology Organization ; 9, Heft 11 (2017), 1558-1573 (gesamt 16)
- Creator
-
Milani, Michela
Annoni, Andrea
Bartolaccini, Sara
Biffi, Mauro
Russo, Fabio
Di Tomaso, Tiziano
Raimondi, Andrea
Lengler, Johannes
Holmes, Michael C.
Scheiflinger, Friedrich
Lombardo, Angelo
Cantore, Alessio
Naldini, Luigi
- DOI
-
10.15252/emmm.201708148
- URN
-
urn:nbn:de:101:1-2022092905483718483181
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Milani, Michela
- Annoni, Andrea
- Bartolaccini, Sara
- Biffi, Mauro
- Russo, Fabio
- Di Tomaso, Tiziano
- Raimondi, Andrea
- Lengler, Johannes
- Holmes, Michael C.
- Scheiflinger, Friedrich
- Lombardo, Angelo
- Cantore, Alessio
- Naldini, Luigi
Other Objects (12)
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted cell entry of lentiviral vectors
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
High yield sterile filtration process for highly concentrated lentiviral vectors
Lentiviral vectors as a tool for studying ependyma-specific proteins
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization
Lentiviral vectors can be used for full-length dystrophin gene therapy
Reconstructing the immune system with lentiviral vectors
Development of DC-specific lentiviral vectors : novel DC-targeting strategies for immunomodulation
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted cell entry of lentiviral vectors
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
High yield sterile filtration process for highly concentrated lentiviral vectors
Lentiviral vectors as a tool for studying ependyma-specific proteins
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization
Lentiviral vectors can be used for full-length dystrophin gene therapy
Reconstructing the immune system with lentiviral vectors
Development of DC-specific lentiviral vectors : novel DC-targeting strategies for immunomodulation
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted cell entry of lentiviral vectors
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
High yield sterile filtration process for highly concentrated lentiviral vectors
Lentiviral vectors as a tool for studying ependyma-specific proteins
Optimized lentiviral gene therapeutic vectors for prolonged and stable transgene expression
Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization
Lentiviral vectors can be used for full-length dystrophin gene therapy
Reconstructing the immune system with lentiviral vectors